Maria A Lopez-Olivo1, Jennifer A Minnix2, James G Fox3, Shawn P E Nishi4, Lisa M Lowenstein1, Kristin G Maki1, Viola B Leal1, Ya-Chen Tina Shih1, Paul M Cinciripini2, Robert J Volk1. 1. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2. Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 3. Division of Pulmonary & Critical Care Medicine, The University of Texas, Health East Texas, Tyler, TX, USA. 4. Division of Pulmonary & Critical Care Medicine, The University of Texas Medical Branch, Galveston, TX, USA.
Abstract
OBJECTIVE: We describe primary care providers' current practice patterns related to smoking cessation counseling and lung cancer screening (LCS). METHODS: Family, internal medicine, and pulmonary medicine providers from two medical centers were asked to complete an electronic survey to report their practice patterns. RESULTS: Of 52 participating providers, most reported initiating three major components of a smoking cessation intervention often or very often: advise to quit (50, 96%), assess willingness to quit (47, 90%), and assist with counseling or pharmacotherapy (49, 94%). However, other components were less commonly initiated such as arranging follow-ups (only 11 providers indicated recommending them often or very often, 21%) and less than half of providers reported that they often or very often recommend cessation counseling or pharmacotherapy of any type (except varenicline), though family medicine providers were more likely to recommend pharmacotherapy compared to the other specialists (p < 0.01). The majority of providers (47, 92%) reported that they engage in informed/shared decision-making about LCS, although only about one-third (17, 33%) indicated using a patient decision aid. Pulmonary medicine providers were more likely to use decision aids than providers from internal or family medicine (p < 0.04). CONCLUSIONS: Within the context of LCS, primary care providers report often having conversations about smoking cessation with their patients who smoke, have no clear preference for type of treatment, and rarely use follow-up calls or visits pertaining to quitting smoking. While many providers report engaging in shared decision-making about LCS, few use a decision aid for this conversation.
OBJECTIVE: We describe primary care providers' current practice patterns related to smoking cessation counseling and lung cancer screening (LCS). METHODS: Family, internal medicine, and pulmonary medicine providers from two medical centers were asked to complete an electronic survey to report their practice patterns. RESULTS: Of 52 participating providers, most reported initiating three major components of a smoking cessation intervention often or very often: advise to quit (50, 96%), assess willingness to quit (47, 90%), and assist with counseling or pharmacotherapy (49, 94%). However, other components were less commonly initiated such as arranging follow-ups (only 11 providers indicated recommending them often or very often, 21%) and less than half of providers reported that they often or very often recommend cessation counseling or pharmacotherapy of any type (except varenicline), though family medicine providers were more likely to recommend pharmacotherapy compared to the other specialists (p < 0.01). The majority of providers (47, 92%) reported that they engage in informed/shared decision-making about LCS, although only about one-third (17, 33%) indicated using a patient decision aid. Pulmonary medicine providers were more likely to use decision aids than providers from internal or family medicine (p < 0.04). CONCLUSIONS: Within the context of LCS, primary care providers report often having conversations about smoking cessation with their patients who smoke, have no clear preference for type of treatment, and rarely use follow-up calls or visits pertaining to quitting smoking. While many providers report engaging in shared decision-making about LCS, few use a decision aid for this conversation.
Authors: Virginia P Quinn; Jack F Hollis; K Sabina Smith; Nancy A Rigotti; Leif I Solberg; Weiming Hu; Victor J Stevens Journal: J Gen Intern Med Date: 2008-12-13 Impact factor: 5.128
Authors: Rebecca J Williams; Andrew L Masica; Mary Ann McBurnie; Leif I Solberg; Steffani R Bailey; Brian Hazlehurst; Stephen E Kurtz; Andrew E Williams; Jon E Puro; Victor J Stevens Journal: Am J Manag Care Date: 2014-03-01 Impact factor: 2.229
Authors: Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck Journal: JAMA Date: 2012-06-13 Impact factor: 56.272
Authors: Jason M Satterfield; Steven E Gregorich; Sara Kalkhoran; Paula J Lum; Jessica Bloome; Nicholas Alvarado; Ricardo F Muñoz; Maya Vijayaraghavan Journal: Am J Prev Med Date: 2018-06-18 Impact factor: 5.043
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Clayton H Brown; Deborah Medoff; Faith B Dickerson; Li Juan Fang; Alicia Lucksted; Richard W Goldberg; Julie Kreyenbuhl; Seth Himelhoch; Lisa B Dixon Journal: J Dual Diagn Date: 2015
Authors: Robert J Volk; Suzanne K Linder; Viola B Leal; Vance Rabius; Paul M Cinciripini; Geetanjali R Kamath; Reginald F Munden; Therese B Bevers Journal: Prev Med Date: 2014-02-08 Impact factor: 4.018
Authors: Maya Vijayaraghavan; Patrick Yuan; Steven Gregorich; Paula Lum; Nicole Appelle; Anna Maria Napoles; Sara Kalkhoran; Jason Satterfield Journal: Prev Med Rep Date: 2017-02-21